{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:54:13Z","timestamp":1792036453281,"version":"4.4.0"},"reference-count":148,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","award":["T32TR004366"],"award-info":[{"award-number":["T32TR004366"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Charles Shipley Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Companion animals in veterinary medicine develop multiple naturally occurring diseases analogous to human conditions. We previously reported a comprehensive review on the feasibility, safety, and biologic activity of using novel stem cell therapies to treat a variety of inflammatory conditions in dogs and cats (2008-2015) [Hoffman AM, Dow SW. Concise review: stem cell trials using companion animal disease models. Stem Cells. 2016;34(7):1709-1729. https:\/\/doi.org\/10.1002\/stem.2377]. The purpose of this review is to provide an updated summary of current studies in companion animal disease models that have evaluated stem cell therapeutics that are relevant to human disease. Here we have reviewed the literature from 2015 to 2023 for publications on stem cell therapies that have been evaluated in companion animals, including dogs, cats, and horses. The review excluded case reports or studies performed in experimentally induced models of disease, studies involving cancer, or studies in purpose-bred laboratory species such as rodents. We identified 45 manuscripts meeting these criteria, an increase from 19 that were described in the previous review [Hoffman AM, Dow SW. Concise review: stem cell trials using companion animal disease models. Stem Cells. 2016;34(7):1709-1729. https:\/\/doi.org\/10.1002\/stem.2377]. The majority of studies were performed in dogs (n\u2005=\u200528), with additional studies in horses (n\u2005=\u20059) and cats (n\u2005=\u20058). Disease models included those related to musculoskeletal disease (osteoarthritis and tendon\/ligament injury), neurologic disease (canine cognitive dysfunction, intervertebral disc disease, spinal cord injury) gingival\/dental disease (gingivostomatitis), dermatologic disease (atopic dermatitis), chronic multi-drug resistant infections, ophthalmic disease (keratoconjunctivitis sicca, eosinophilic keratitis, immune-mediated keratitis), cardiopulmonary disease (asthma, degenerative valve disease, dilated cardiomyopathy), gastrointestinal disease (inflammatory bowel disease, chronic enteropathy), and renal disease (chronic kidney disease). The majority of studies reported beneficial responses to stem cell treatment, with the exception of those related to more chronic processes such as spinal cord injury and chronic kidney disease. However, it should also be noted that 22 studies were open-label, baseline-controlled trials and only 12 studies were randomized and controlled, making overall study interpretation difficult. As noted in the previous review, improved regulatory oversight and consistency in manufacturing of stem cell therapies are needed. Enhanced understanding of the temporal course of disease processes using advanced-omics approaches may further inform mechanisms of action and help define appropriate timing of interventions. Future directions of stem-cell-based therapies could include use of stem-cell-derived extracellular vesicles, or cell conditioning approaches to direct cells to specific pathways that are tailored to individual disease processes and stages of illness.<\/jats:p>","DOI":"10.1093\/stmcls\/sxae034","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T17:26:13Z","timestamp":1716571573000},"page":"677-705","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of stem-cell therapies in companion animal disease models: a concise review (2015-2023)"],"prefix":"10.1093","volume":"42","author":[{"given":"Zo\u00eb J","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO 80523 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4990-5006","authenticated-orcid":false,"given":"Lynn M","family":"Pezzanite","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO 80523 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndah","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO 80523 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Rockow","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO 80523 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W","family":"Dow","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University , Fort Collins, CO 80523 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"issue":"7","key":"2026032806233517900_CIT0001","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/stem.2377","article-title":"Concise review: stem cell trials using companion animal disease models","volume":"34","author":"Hoffman","year":"2016","journal-title":"Stem Cells"},{"issue":"308","key":"2026032806233517900_CIT0002","doi-asserted-by":"crossref","first-page":"308ps","DOI":"10.1126\/scitranslmed.aaa9116","article-title":"Companion animals: translational scientist\u2019s new best friends","volume":"7","author":"Kol","year":"2015","journal-title":"Sci Transl Med"},{"issue":"2","key":"2026032806233517900_CIT0003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/scrt171","article-title":"Large animal models for stem cell therapy","volume":"4","author":"Harding","year":"2013","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"2026032806233517900_CIT0004","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/1098612X221090390","article-title":"Feline Comorbidities: Balancing hyperthyroidism and concurrent chronic kidney disease","volume":"24","author":"Geddes","year":"2022","journal-title":"J Feline Med Surg"},{"issue":"7","key":"2026032806233517900_CIT0005","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/1098612X211021538","article-title":"2021 AAFP Feline Senior Care Guidelines","volume":"23","author":"Ray","year":"2021","journal-title":"J Feline Med Surg"},{"issue":"1","key":"2026032806233517900_CIT0006","doi-asserted-by":"crossref","first-page":"1098612X2211400","DOI":"10.1177\/1098612X221140081","article-title":"Ultrasonographic monitoring of feline epaxial muscle height as part of an annual wellness examination to assess for the development of sarcopenia","volume":"25","author":"Lutchman","year":"2023","journal-title":"J Feline Med Surg"},{"issue":"11","key":"2026032806233517900_CIT0007","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1098612X20965832","article-title":"Feline musculoskeletal ageing: How are we diagnosing and treating musculoskeletal impairment","volume":"22","author":"Dowgray","year":"2020","journal-title":"J Feline Med Surg"},{"issue":"1","key":"2026032806233517900_CIT0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0195-5616(93)50009-8","article-title":"Feline gingivitis-stomatitis-pharyngitis","volume":"23","author":"Diehl","year":"1993","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026032806233517900_CIT0009","first-page":"34","article-title":"An updated approach to chronic feline gingivitis stomatitis syndrome","volume":"44","author":"Johnston","year":"2012","journal-title":"Veterinary Pract"},{"issue":"4","key":"2026032806233517900_CIT0010","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1152\/jappl.1987.63.4.1344","article-title":"The English bulldog: a natural model of sleep-disordered breathing","volume":"63","author":"Hendricks","year":"1987","journal-title":"J Appl Physiol"},{"issue":"13","key":"2026032806233517900_CIT0011","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/vr.k1403","article-title":"Brachycephalic obstructive airway syndrome","volume":"182","author":"Ladlow","year":"2018","journal-title":"Vet Rec"},{"issue":"8","key":"2026032806233517900_CIT0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.2044-3862.2009.tb00408.x","article-title":"Surgery of the upper respiratory tract Part 2: Brachycephalic obstructive airway syndrome (BOAS)","volume":"14","author":"Bowlt","year":"2009","journal-title":"Compan Anim"},{"key":"2026032806233517900_CIT0013","doi-asserted-by":"crossref","first-page":"1235821","DOI":"10.3389\/fgene.2023.1235821","article-title":"Uncovering structural variants associated with body weight and obesity risk in labrador retrievers: a genome-wide study","volume":"14","author":"Antkowiak","year":"2023","journal-title":"Front Genet"},{"issue":"6","key":"2026032806233517900_CIT0014","doi-asserted-by":"crossref","first-page":"e3410","DOI":"10.1002\/vetr.3410","article-title":"Obesity risk factors in British Labrador retrievers: Effect of sex, neuter status, age, chocolate coat colour and food motivation","volume":"194","author":"Wallis","year":"2023","journal-title":"Vet Rec"},{"key":"2026032806233517900_CIT0015","volume-title":"Medical, Genetic & Behavioral Risk Factors of Beagles","author":"Clark","year":"2014"},{"issue":"5","key":"2026032806233517900_CIT0016","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.1980.tb07862.x","article-title":"Amino acid changes in a genetic strain of epileptic beagle dogs","volume":"35","author":"van Gelder","year":"1980","journal-title":"J Neurochem"},{"key":"2026032806233517900_CIT0017","doi-asserted-by":"crossref","first-page":"2041731419894361","DOI":"10.1177\/2041731419894361","article-title":"EphrinB2 regulates osteogenic differentiation of periodontal ligament stem cells and alveolar bone defect regeneration in beagles","volume":"10","author":"Wang","year":"2019","journal-title":"J Tissue Eng"},{"issue":"5","key":"2026032806233517900_CIT0018","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00439-019-01973-2","article-title":"A missense variant in the titin gene in Doberman pinscher dogs with familial dilated cardiomyopathy and sudden cardiac death","volume":"138","author":"Meurs","year":"2019","journal-title":"Hum Genet"},{"issue":"9","key":"2026032806233517900_CIT0019","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2460\/javma.2000.216.1414","article-title":"Breed distribution of dogs with diabetes mellitus admitted to a tertiary care facility","volume":"216","author":"Hess","year":"2000","journal-title":"J Am Vet Med Assoc"},{"issue":"10","key":"2026032806233517900_CIT0020","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3390\/ani10101895","article-title":"A genomic study of myxomatous mitral valve disease in Cavalier King Charles Spaniels","volume":"10","author":"Bionda","year":"2020","journal-title":"Animals (Basel)"},{"issue":"12","key":"2026032806233517900_CIT0021","doi-asserted-by":"crossref","first-page":"e0274724","DOI":"10.1371\/journal.pone.0274724","article-title":"Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study","volume":"17","author":"Ghilardi","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"2026032806233517900_CIT0022","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12917-020-02542-w","article-title":"Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel","volume":"16","author":"Markby","year":"2020","journal-title":"BMC Vet Res"},{"key":"2026032806233517900_CIT0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jvc.2021.09.004","article-title":"Screening for dilated cardiomyopathy in dogs","volume":"40","author":"Wess","year":"2022","journal-title":"J Vet Cardiol"},{"key":"2026032806233517900_CIT0024","doi-asserted-by":"crossref","first-page":"105535","DOI":"10.1016\/j.tvjl.2020.105535","article-title":"The role of atrial fibrillation as a prognostic factor in doberman pinschers with dilated cardiomyopathy and congestive heart failure","volume":"264","author":"Friederich","year":"2020","journal-title":"Vet J"},{"issue":"5","key":"2026032806233517900_CIT0025","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/0300985820934112","article-title":"Polyneuropathy in young Siberian Huskies caused by degenerative and inflammatory diseases","volume":"57","author":"Jahns","year":"2020","journal-title":"Vet Pathol"},{"key":"2026032806233517900_CIT0026","doi-asserted-by":"crossref","first-page":"590558","DOI":"10.3389\/fimmu.2020.590558","article-title":"Case series: Gene expression analysis in canine Vogt-Koyanagi-Harada\/uveodermatologic syndrome and vitiligo reveals conserved immunopathogenesis pathways between dog and human autoimmune pigmentary disorders","volume":"11","author":"Egbeto","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"2026032806233517900_CIT0027","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2460\/javma.238.8.1011","article-title":"Association of hypertriglyceridemia with insulin resistance in healthy Miniature Schnauzers","volume":"238","author":"Xenoulis","year":"2011","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"2026032806233517900_CIT0028","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40575-020-00096-6","article-title":"Breeding schemes for intervertebral disc disease in dachshunds: Is disc calcification score preferable to genotyping of the FGF4 retrogene insertion on CFA12","volume":"7","author":"Bruun","year":"2020","journal-title":"Canine Med Genet"},{"issue":"S1","key":"2026032806233517900_CIT0029","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2474-16-S1-S11","article-title":"Canine chondrodystrophic intervertebral disc disease (Hansen type I disc disease)","volume":"16","author":"Rusbridge","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"issue":"10","key":"2026032806233517900_CIT0030","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.joca.2012.06.005","article-title":"Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles","volume":"20","author":"Malda","year":"2012","journal-title":"Osteoarthr Cartil"},{"issue":"11","key":"2026032806233517900_CIT0031","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1302\/2046-3758.111.2000132","article-title":"The horse as a model of naturally occurring osteoarthritis","volume":"1","author":"McIlwraith","year":"2012","journal-title":"Bone Joint Res"},{"issue":"1","key":"2026032806233517900_CIT0032","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.otsm.2016.12.007","article-title":"Equine models for the investigation of mesenchymal stem cell therapies in orthopaedic disease","volume":"25","author":"Colbath","year":"2017","journal-title":"Oper Tech Sports Med"},{"key":"2026032806233517900_CIT0033","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fvets.2017.00158","article-title":"Tenogenically induced allogeneic peripheral blood mesenchymal stem cells in allogeneic platelet-rich plasma: 2-year follow-up after tendon or ligament treatment in horses","volume":"4","author":"Beerts","year":"2017","journal-title":"Front Vet Sci"},{"issue":"6","key":"2026032806233517900_CIT0034","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/evj.13922","article-title":"Treatment of racehorse superficial digital flexor tendonitis: a comparison of stem cell treatments to controlled exercise rehabilitation in 213 cases","volume":"55","author":"Salz","year":"2023","journal-title":"Equine Vet J"},{"issue":"7","key":"2026032806233517900_CIT0035","doi-asserted-by":"crossref","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"issue":"Suppl 1","key":"2026032806233517900_CIT0036","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.4103\/sja.SJA_559_18","article-title":"The CONSORT statement","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"issue":"17","key":"2026032806233517900_CIT0037","doi-asserted-by":"crossref","first-page":"e2103238118","DOI":"10.1073\/pnas.2103238118","article-title":"The MDAR (Materials Design Analysis Reporting) framework for transparent reporting in the life sciences","volume":"118","author":"Macleod","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2026032806233517900_CIT0038","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1532-950X.2014.12289.x","article-title":"Scintigraphic tracking of mesenchymal stem cells after intravenous regional limb perfusion and subcutaneous administration in the standing horse","volume":"44","author":"Spriet","year":"2015","journal-title":"Vet Surg"},{"issue":"3","key":"2026032806233517900_CIT0039","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/vru.12243","article-title":"Scintigraphic tracking of mesenchymal stem cells after portal, systemic intravenous and splenic administration in healthy beagle dogs","volume":"56","author":"Spriet","year":"2015","journal-title":"Vet Radiol Ultrasound"},{"issue":"1","key":"2026032806233517900_CIT0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jvim.13655","article-title":"Safety of intraperitoneal injection of adipose tissue-derived autologous mesenchymal stem cells in cats","volume":"30","author":"Parys","year":"2016","journal-title":"J Vet Intern Med"},{"issue":"1","key":"2026032806233517900_CIT0041","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13287-017-0503-8","article-title":"Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model","volume":"8","author":"Joswig","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"2026032806233517900_CIT0042","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.scr.2017.11.010","article-title":"Safety and immune regulatory properties of canine induced pluripotent stem cell-derived mesenchymal stem cells","volume":"25","author":"Chow","year":"2017","journal-title":"Stem Cell Res"},{"key":"2026032806233517900_CIT0043","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"2026032806233517900_CIT0044","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/art.1780160317","article-title":"Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit","volume":"16","author":"Moskowitz","year":"1973","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2026032806233517900_CIT0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/ard.32.4.387","article-title":"Experimentally-induced osteoarthritis in the dog","volume":"32","author":"Pond","year":"1973","journal-title":"Ann Rheum Dis"},{"issue":"Pt 2","key":"2026032806233517900_CIT0046","first-page":"425","article-title":"Ultrastructural changes in articular cartilage after experimental section of the anterior cruciate ligament of the dog knee","volume":"136","author":"Stockwell","year":"1983","journal-title":"J Anat"},{"issue":"2","key":"2026032806233517900_CIT0047","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1208\/s12248-013-9454-x","article-title":"Animal models of osteoarthritis: challenges of model selection and analysis","volume":"15","author":"Teeple","year":"2013","journal-title":"AAPS J"},{"issue":"5","key":"2026032806233517900_CIT0048","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/0300985815588611","article-title":"Animal models of osteoarthritis: comparisons and key considerations","volume":"52","author":"McCoy","year":"2015","journal-title":"Vet Pathol"},{"issue":"4","key":"2026032806233517900_CIT0049","first-page":"363","article-title":"Animal models of osteoarthritis","volume":"1","author":"Bendele","year":"2001","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"4","key":"2026032806233517900_CIT0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0195-5616(97)50076-3","article-title":"Osteoarthritis. Joint anatomy, physiology, and pathobiology","volume":"27","author":"Johnston","year":"1997","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026032806233517900_CIT0051","volume-title":"Diagnosis and Management of Lameness in the Horse","author":"Ross","year":"2010"},{"key":"2026032806233517900_CIT0052","volume-title":"Lameness and laminitis in US horses","author":"United States Department of Agriculture","year":"2000"},{"issue":"5","key":"2026032806233517900_CIT0053","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1532-950X.2010.00708.x","article-title":"Cross-sectional study of the prevalence of radiographic degenerative joint disease in domesticated cats","volume":"39","author":"Lascelles","year":"2010","journal-title":"Vet Surg"},{"issue":"4","key":"2026032806233517900_CIT0054","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/jvim.13972","article-title":"A feline-specific anti-nerve growth factor antibody improves mobility in cats with degenerative joint disease-associated pain: A pilot proof of concept study","volume":"30","author":"Gruen","year":"2016","journal-title":"J Vet Intern Med"},{"issue":"6","key":"2026032806233517900_CIT0055","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1111\/jvim.16291","article-title":"Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats","volume":"35","author":"Gruen","year":"2021","journal-title":"J Vet Intern Med"},{"key":"2026032806233517900_CIT0056","doi-asserted-by":"crossref","first-page":"610028","DOI":"10.3389\/fvets.2021.610028","article-title":"Efficacy and safety of an anti-nerve growth factor antibody (frunevetmab) for the treatment of degenerative joint disease-associated chronic pain in cats: a multisite pilot field study","volume":"8","author":"Gruen","year":"2021","journal-title":"Front Vet Sci"},{"key":"2026032806233517900_CIT0057","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fvets.2016.00061","article-title":"The use of adipose-derived progenitor cells and platelet-rich plasma combination for the treatment of supraspinatus tendinopathy in 55 dogs: a retrospective study","volume":"3","author":"Canapp","year":"2016","journal-title":"Front Vet Sci"},{"key":"2026032806233517900_CIT0058","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fvets.2016.00112","article-title":"Partial cranial cruciate ligament tears treated with stem cell and platelet-rich plasma combination therapy in 36 dogs: a retrospective study","volume":"3","author":"Canapp","year":"2016","journal-title":"Front Vet Sci"},{"issue":"8","key":"2026032806233517900_CIT0059","doi-asserted-by":"crossref","first-page":"e0159095","DOI":"10.1371\/journal.pone.0159095","article-title":"Autologous bone marrow-derived mesenchymal stem cells modulate molecular markers of inflammation in dogs with cruciate ligament rupture","volume":"11","author":"Muir","year":"2016","journal-title":"PLoS One"},{"key":"2026032806233517900_CIT0060","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fvets.2019.00474","article-title":"Intra-articular umbilical cord derived mesenchymal stem cell therapy for chronic elbow osteoarthritis in dogs: a double-blinded, placebo-controlled clinical trial","volume":"6","author":"Kim","year":"2019","journal-title":"Front Vet Sci"},{"issue":"11-12","key":"2026032806233517900_CIT0061","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/scd.2022.0296","article-title":"Intravenous injection of equine mesenchymal stem cells in dogs with articular pain and lameness: a feasibility study","volume":"32","author":"Brondeel","year":"2023","journal-title":"Stem Cells Dev"},{"key":"2026032806233517900_CIT0062","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fvets.2019.00010","article-title":"Long-term safety and efficacy of single or repeated intra-articular injection of allogeneic neonatal mesenchymal stromal cells for managing pain and lameness in moderate to severe canine osteoarthritis without anti-inflammatory pharmacological support: pilot clinical study","volume":"6","author":"Cabon","year":"2019","journal-title":"Front Vet Sci"},{"issue":"4","key":"2026032806233517900_CIT0063","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.21873\/invivo.11580","article-title":"The use of allogenic stromal vascular fraction (SVF) cells in degenerative joint disease of the spine in dogs","volume":"33","author":"Kemilew","year":"2019","journal-title":"In Vivo"},{"issue":"6","key":"2026032806233517900_CIT0064","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/scd.2018.0061","article-title":"Equine allogeneic chondrogenic induced mesenchymal stem cells are an effective treatment for degenerative joint disease in horses","volume":"28","author":"Broeckx","year":"2019","journal-title":"Stem Cells Dev"},{"issue":"8","key":"2026032806233517900_CIT0065","doi-asserted-by":"crossref","first-page":"e0221317","DOI":"10.1371\/journal.pone.0221317","article-title":"Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal\/metatarsophalangeal joint in horses: a clinical pilot study","volume":"14","author":"Magri","year":"2019","journal-title":"PLoS One"},{"key":"2026032806233517900_CIT0066","doi-asserted-by":"crossref","first-page":"7309201","DOI":"10.1155\/2018\/7309201","article-title":"Outcome of allogeneic adult stem cell therapy in dogs suffering from osteoarthritis and other joint defects","volume":"2018","author":"Shah","year":"2018","journal-title":"Stem Cells Int"},{"key":"2026032806233517900_CIT0067","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fvets.2016.00081","article-title":"A prospective, randomized, masked, and placebo-controlled efficacy study of intraarticular allogeneic adipose stem cells for the treatment of osteoarthritis in dogs","volume":"3","author":"Harman","year":"2016","journal-title":"Front Vet Sci"},{"issue":"3","key":"2026032806233517900_CIT0068","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1556\/004.2018.034","article-title":"The use of canine mesenchymal stem cells for the autologous treatment of osteoarthritis","volume":"66","author":"Srzenti\u0107 Dra\u017eilov","year":"2018","journal-title":"Acta Vet Hung"},{"issue":"17","key":"2026032806233517900_CIT0069","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/scd.2018.0074","article-title":"Allogeneic adipose-derived mesenchymal stem cells (Horse Allo 20) for the treatment of osteoarthritis-associated lameness in horses: characterization, safety, and efficacy of intra-articular treatment","volume":"27","author":"Mari\u00f1as-Pardo","year":"2018","journal-title":"Stem Cells Dev"},{"key":"2026032806233517900_CIT0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fvets.2017.00083","article-title":"Evaluation of the effect of a single intra-articular injection of allogeneic neonatal mesenchymal stromal cells compared to oral non-steroidal anti-inflammatory treatment on the postoperative musculoskeletal status and gait of dogs over a 6-month period after Tibial plateau leveling osteotomy: a pilot study","volume":"4","author":"Taroni","year":"2017","journal-title":"Front Vet Sci"},{"issue":"3","key":"2026032806233517900_CIT0071","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrn2091","article-title":"The elephant in the room\u2014healthy brains in later life, epidemiology and public health","volume":"8","author":"Brayne","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2026032806233517900_CIT0072","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13287-022-02933-w","article-title":"Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial","volume":"13","author":"Valenzuela","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"2026032806233517900_CIT0073","first-page":"675","article-title":"The effects of aging on the behavior of senior pets","volume":"35","author":"Landsberg","year":"2005","journal-title":"Handbook of Behavior Problems."},{"issue":"3","key":"2026032806233517900_CIT0074","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tvjl.2010.05.014","article-title":"The canine cognitive dysfunction rating scale (CCDR): a data-driven and ecologically relevant assessment tool","volume":"188","author":"Salvin","year":"2011","journal-title":"Vet J"},{"issue":"18","key":"2026032806233517900_CIT0075","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1097\/BRS.0b013e3181cd656f","article-title":"Low back pain in primary care: costs of care and prediction of future health care utilization","volume":"35","author":"Becker","year":"2010","journal-title":"Spine"},{"issue":"6","key":"2026032806233517900_CIT0076","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/jvim.12183","article-title":"Intervertebral disk degeneration in dogs: consequences, diagnosis, treatment, and future directions","volume":"27","author":"Jeffery","year":"2013","journal-title":"J Vet Intern Med"},{"issue":"3","key":"2026032806233517900_CIT0077","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00701-009-0529-5","article-title":"Overview of disc arthroplasty-past, present and future","volume":"152","author":"Fekete","year":"2010","journal-title":"Acta Neurochir"},{"issue":"18","key":"2026032806233517900_CIT0078","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1097\/01.brs.0000231761.73859.2c","article-title":"What is intervertebral disc degeneration, and what causes it","volume":"31","author":"Adams","year":"2006","journal-title":"Spine"},{"issue":"11","key":"2026032806233517900_CIT0079","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/ten.tec.2017.0033","article-title":"Bone marrow-derived mesenchymal stem cells as autologous therapy in dogs with naturally occurring intervertebral disc disease: feasibility, safety, and preliminary results","volume":"23","author":"Steffen","year":"2017","journal-title":"Tissue Eng Part C Methods"},{"key":"2026032806233517900_CIT0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fvets.2019.00383","article-title":"Comparison of the efficacy of surgical decompression alone and combined with canine adipose tissue-derived stem cell transplantation in dogs with acute thoracolumbar disk disease and spinal cord injury","volume":"6","author":"Bach","year":"2019","journal-title":"Front Vet Sci"},{"issue":"3","key":"2026032806233517900_CIT0081","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1002\/jcp.27086","article-title":"An allogenic therapeutic strategy for canine spinal cord injury using mesenchymal stem cells","volume":"234","author":"Bhat","year":"2019","journal-title":"J Cell Physiol"},{"issue":"9","key":"2026032806233517900_CIT0082","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1292\/jvms.15-0571","article-title":"The use of autologous neurogenically-induced bone marrow-derived mesenchymal stem cells for the treatment of paraplegic dogs without nociception due to spinal trauma","volume":"78","author":"Besalti","year":"2016","journal-title":"J Vet Med Sci"},{"key":"2026032806233517900_CIT0083","doi-asserted-by":"crossref","first-page":"575938","DOI":"10.3389\/fvets.2020.575938","article-title":"Generation of neural progenitor cells from canine induced pluripotent stem cells and preliminary safety test in dogs with spontaneous spinal cord injuries","volume":"7","author":"Chow","year":"2020","journal-title":"Front Vet Sci"},{"issue":"Suppl 2","key":"2026032806233517900_CIT0084","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0195-6701(08)60017-1","article-title":"Surgical site infections: epidemiology, microbiology and prevention","volume":"70","author":"Owens","year":"2008","journal-title":"J Hosp Infect"},{"issue":"1","key":"2026032806233517900_CIT0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/wound.2014.0535","article-title":"Association between microbial bioburden and healing outcomes in venous leg ulcers: a review of the evidence","volume":"4","author":"Tuttle","year":"2015","journal-title":"Adv Wound Care"},{"issue":"1","key":"2026032806233517900_CIT0086","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5966\/sctm.2015-0127","article-title":"Therapeutic efficacy of fresh, autologous mesenchymal stem cells for severe refractory gingivostomatitis in cats","volume":"5","author":"Arzi","year":"2016","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"2026032806233517900_CIT0087","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/jdv.16892","article-title":"ETFAD\/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children","volume":"34","author":"Wollenberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026032806233517900_CIT0088","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fimmu.2017.00339","article-title":"Antimicrobial activity of mesenchymal stem cells: current status and new perspectives of antimicrobial peptide-based therapies","volume":"8","author":"Alcayaga-Miranda","year":"2017","journal-title":"Front Immunol"},{"issue":"21","key":"2026032806233517900_CIT0089","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/vr.104867","article-title":"Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety","volume":"183","author":"Villatoro","year":"2018","journal-title":"Vet Rec"},{"issue":"Suppl 1","key":"2026032806233517900_CIT0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/dmrr.2747","article-title":"What\u2019s new in wound treatment: a critical appraisal","volume":"32","author":"Garwood","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"2026032806233517900_CIT0091","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3389\/fmicb.2016.01559","article-title":"Editorial: alternative therapeutics against MDR Bacteria \u2013 \u201cFighting the Epidemic of Antibiotic Resistance.\u201d","volume":"7","author":"Martins","year":"2016","journal-title":"Front Microbiol"},{"issue":"21","key":"2026032806233517900_CIT0092","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.21037\/atm-22-1746","article-title":"TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant Staphylococcal septic arthritis in an equine model","volume":"10","author":"Pezzanite","year":"2022","journal-title":"Ann Transl Med"},{"issue":"12","key":"2026032806233517900_CIT0093","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"issue":"1","key":"2026032806233517900_CIT0094","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13287-017-0610-6","article-title":"Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds","volume":"8","author":"Harman","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2026032806233517900_CIT0095","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1038\/s41598-017-08311-4","article-title":"Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections","volume":"7","author":"Johnson","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"2026032806233517900_CIT0096","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/s41598-020-59724-7","article-title":"Safety and efficacy of a mesenchymal stem cell intramammary therapy in dairy cows with experimentally induced Staphylococcus aureus clinical mastitis","volume":"10","author":"Peralta","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"2026032806233517900_CIT0097","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/sctm.19-0333","article-title":"The mesenchymal stromal cell secretome impairs methicillin-resistant Staphylococcus aureus biofilms via cysteine protease activity in the equine model","volume":"9","author":"Marx","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"2026032806233517900_CIT0098","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fvets.2019.00443","article-title":"Antimicrobial effects of conditioned medium from amniotic progenitor cells in vitro and in vivo: toward tissue regenerative therapies for bovine mastitis","volume":"6","author":"Lange-Consiglio","year":"2019","journal-title":"Front Vet Sci"},{"key":"2026032806233517900_CIT0099","doi-asserted-by":"crossref","first-page":"925701","DOI":"10.3389\/fvets.2022.925701","article-title":"Activated mesenchymal stromal cell therapy for treatment of multi-drug resistant bacterial infections in dogs","volume":"9","author":"Johnson","year":"2022","journal-title":"Front Vet Sci"},{"issue":"5","key":"2026032806233517900_CIT0100","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"2026032806233517900_CIT0101","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4314\/ovj.v8i1.8","article-title":"Immunohistochemical evaluation of lymphocyte populations in the nictitans glands of normal dogs and dogs with keratoconjunctivitis sicca","volume":"8","author":"Williams","year":"2018","journal-title":"Open Vet J"},{"issue":"4","key":"2026032806233517900_CIT0102","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.survophthal.2011.11.003","article-title":"Evaluation of dry eye","volume":"57","author":"McGinnigle","year":"2012","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"2026032806233517900_CIT0103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"2026032806233517900_CIT0104","first-page":"2609","article-title":"Conjunctival T-cell subpopulations in Sj\u00f6gren\u2019s and non-Sj\u00f6gren\u2019s patients with dry eye","volume":"43","author":"Stern","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2026032806233517900_CIT0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12917-018-1413-4","article-title":"Safety and efficacy of the mesenchymal stem cell in feline eosinophilic keratitis treatment","volume":"14","author":"Villatoro","year":"2018","journal-title":"BMC Vet Res"},{"issue":"5","key":"2026032806233517900_CIT0106","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/vop.12641","article-title":"Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: a case series","volume":"22","author":"Davis","year":"2019","journal-title":"Vet Ophthalmol"},{"issue":"2","key":"2026032806233517900_CIT0107","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s10753-020-01362-2","article-title":"The role of neutrophils in the pathophysiology of asthma in humans and horses","volume":"44","author":"Davis","year":"2021","journal-title":"Inflammation"},{"issue":"1","key":"2026032806233517900_CIT0108","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13287-022-02704-7","article-title":"Effect of intrabronchial administration of autologous adipose-derived mesenchymal stem cells on severe equine asthma","volume":"13","author":"Adami\u010d","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"2026032806233517900_CIT0109","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41569-021-00570-z","article-title":"Global epidemiology of valvular heart disease","volume":"18","author":"Coffey","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2026032806233517900_CIT0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jvc.2012.01.011","article-title":"Historical review, epidemiology and natural history of degenerative mitral valve disease","volume":"14","author":"Borgarelli","year":"2012","journal-title":"J Vet Cardiol"},{"key":"2026032806233517900_CIT0111","doi-asserted-by":"crossref","first-page":"107196","DOI":"10.1016\/j.carpath.2019.107196","article-title":"Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-\u03b2 mechanisms","volume":"46","author":"Oyama","year":"2020","journal-title":"Cardiovasc Pathol"},{"issue":"2","key":"2026032806233517900_CIT0112","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0008-6363(00)00113-9","article-title":"Mitral valve prolapse in the dog: a model of mitral valve prolapse in man","volume":"47","author":"Pedersen","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"12","key":"2026032806233517900_CIT0113","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.14202\/vetworld.2016.1429-1434","article-title":"Intravenous administration of puppy deciduous teeth stem cells in degenerative valve disease","volume":"9","author":"Petchdee","year":"2016","journal-title":"Vet World"},{"issue":"27","key":"2026032806233517900_CIT0114","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"N Engl J Med"},{"key":"2026032806233517900_CIT0115","first-page":"1","article-title":"Stem cell therapeutics: potential in the treatment of inflammatory bowel disease","volume":"3","author":"Swenson","year":"2010","journal-title":"Clin Exp Gastroenterol"},{"issue":"3","key":"2026032806233517900_CIT0116","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tvjl.2015.07.023","article-title":"Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomes","volume":"206","author":"P\u00e9rez-Merino","year":"2015","journal-title":"Vet J"},{"issue":"3","key":"2026032806233517900_CIT0117","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tvjl.2015.08.003","article-title":"Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes","volume":"206","author":"P\u00e9rez-Merino","year":"2015","journal-title":"Vet J"},{"issue":"10","key":"2026032806233517900_CIT0118","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/1098612X14561105","article-title":"Stem cell therapy in cats with chronic enteropathy: a proof-of-concept study","volume":"17","author":"Webb","year":"2015","journal-title":"J Feline Med Surg"},{"issue":"Suppl 1","key":"2026032806233517900_CIT0119","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1098612X13495248","article-title":"Feline CKD: New horizons\u2014where do we go from here","volume":"15","author":"Taylor","year":"2013","journal-title":"J Feline Med Surg"},{"issue":"1","key":"2026032806233517900_CIT0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/sctm.18-0115","article-title":"Concise reviews: stem cells and kidney regeneration: an update","volume":"8","author":"Marcheque","year":"2019","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"2026032806233517900_CIT0121","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/leu.2011.108","article-title":"Mesenchymal stromal cell \u201clicensing\u201d: a multistep process","volume":"25","author":"Krampera","year":"2011","journal-title":"Leukemia"},{"issue":"18","key":"2026032806233517900_CIT0122","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1089\/scd.2014.0581","article-title":"Licensing by inflammatory cytokines abolishes heterogeneity of immunosuppressive function of mesenchymal stem cell population","volume":"24","author":"Szab\u00f3","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"7","key":"2026032806233517900_CIT0123","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3109\/14653240903253857","article-title":"Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury\/paraplegia: a pilot clinical study","volume":"11","author":"Pal","year":"2009","journal-title":"Cytotherapy"},{"issue":"Pt 9","key":"2026032806233517900_CIT0124","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/brain\/awn173","article-title":"Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial","volume":"131","author":"Mackay-Sim","year":"2008","journal-title":"Brain"},{"issue":"8","key":"2026032806233517900_CIT0125","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1634\/stemcells.2006-0807","article-title":"Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I\/II clinical trial","volume":"25","author":"Yoon","year":"2007","journal-title":"Stem Cells"},{"issue":"1","key":"2026032806233517900_CIT0126","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","article-title":"Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis","volume":"11","author":"Xiang","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"2026032806233517900_CIT0127","doi-asserted-by":"crossref","first-page":"980","DOI":"10.5966\/sctm.2014-0219","article-title":"Cell therapy using human induced pluripotent stem cell-derived renal progenitors ameliorates acute kidney injury in mice","volume":"4","author":"Toyohara","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"11","key":"2026032806233517900_CIT0128","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.3390\/ijms20112790","article-title":"Stem cell therapies in kidney diseases: progress and challenges","volume":"20","author":"Rota","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026032806233517900_CIT0129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13287-018-0840-2","article-title":"Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment","volume":"9","author":"Cassano","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"2026032806233517900_CIT0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5966\/sctm.2012-0025","article-title":"Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy","volume":"1","author":"Waterman","year":"2012","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"2026032806233517900_CIT0131","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/eji.200738129","article-title":"IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease","volume":"38","author":"Polchert","year":"2008","journal-title":"Eur J Immunol"},{"issue":"4","key":"2026032806233517900_CIT0132","doi-asserted-by":"crossref","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","article-title":"A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PLoS One"},{"key":"2026032806233517900_CIT0133","doi-asserted-by":"crossref","first-page":"865601","DOI":"10.1155\/2010\/865601","article-title":"Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential","volume":"2010","author":"DelaRosa","year":"2010","journal-title":"Mediators Inflamm"},{"key":"2026032806233517900_CIT0134","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fimmu.2012.00182","article-title":"Toll-like receptors as modulators of mesenchymal stem cells","volume":"3","author":"Delarosa","year":"2012","journal-title":"Front Immunol"},{"key":"2026032806233517900_CIT0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40364-019-0159-x","article-title":"Exosomes from mesenchymal stem\/stromal cells: a new therapeutic paradigm","volume":"7","author":"Yin","year":"2019","journal-title":"Biomark Res"},{"issue":"2","key":"2026032806233517900_CIT0136","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ijms17020170","article-title":"Focus on extracellular vesicles: introducing the next small big thing","volume":"17","author":"Kalra","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2026032806233517900_CIT0137","doi-asserted-by":"crossref","first-page":"151","DOI":"10.20517\/evcna.2023.11","article-title":"Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans","volume":"4","author":"O\u2019Brien","year":"2023","journal-title":"Extracell Vesicles Circu Nucl Acids"},{"issue":"4","key":"2026032806233517900_CIT0138","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/REP-22-0215","article-title":"Production of extracellular vesicles from equine embryo-derived mesenchymal stromal cells","volume":"164","author":"Tasma","year":"2022","journal-title":"Reproduction"},{"issue":"3","key":"2026032806233517900_CIT0139","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","article-title":"Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake","volume":"36","author":"Abels","year":"2016","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"2026032806233517900_CIT0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cveq.2023.06.005","article-title":"Antimicrobial properties of equine stromal cells and platelets and future directions","volume":"39","author":"Pezzanite","year":"2023","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"2","key":"2026032806233517900_CIT0141","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5966\/sctm.2011-0022","article-title":"Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem\/stromal cells","volume":"1","author":"Chen","year":"2012","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"2026032806233517900_CIT0142","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/sctm.17-0035","article-title":"Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis","volume":"6","author":"Arzi","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"2026032806233517900_CIT0143","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13287-020-01623-9","article-title":"A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis","volume":"11","author":"Arzi","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"2026032806233517900_CIT0144","doi-asserted-by":"crossref","first-page":"101525","DOI":"10.1016\/j.scr.2019.101525","article-title":"Reduction in the inflammatory markers CD4, IL-1, IL-6 and TNF\u03b1 in dogs with keratoconjunctivitis sicca treated topically with mesenchymal stem cells","volume":"39","author":"Sgrignoli","year":"2019","journal-title":"Stem Cell Res"},{"key":"2026032806233517900_CIT0145","doi-asserted-by":"crossref","first-page":"527926","DOI":"10.1155\/2015\/527926","article-title":"Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model","volume":"2015","author":"Villatoro","year":"2015","journal-title":"Biomed Res Int"},{"issue":"8","key":"2026032806233517900_CIT0146","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/jcmm.13077","article-title":"Intracoronary allogeneic cardiosphere-derived stem cells are safe for use in dogs with dilated cardiomyopathy","volume":"21","author":"Hensley","year":"2017","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2026032806233517900_CIT0147","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1098612X15576980","article-title":"Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats","volume":"18","author":"Quimby","year":"2016","journal-title":"J Feline Med Surg"},{"issue":"Suppl 2","key":"2026032806233517900_CIT0148","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/rda.12846","article-title":"Transplantation of amniotic membrane-derived multipotent cells ameliorates and delays the progression of chronic kidney disease in cats","volume":"52","author":"Vidane","year":"2017","journal-title":"Reprod Domest Anim"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stmcls\/advance-article-pdf\/doi\/10.1093\/stmcls\/sxae034\/58102206\/sxae034.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/42\/8\/677\/58703379\/sxae034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/42\/8\/677\/58703379\/sxae034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T10:23:59Z","timestamp":1774693439000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/42\/8\/677\/7682315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":148,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/stmcls\/sxae034","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,5,25]]}}}